Kymera Therapeutics, Inc. (KYMR)
85.80
-0.46
(-0.53%)
USD |
NASDAQ |
May 07, 09:41
Kymera Therapeutics SG&A Expense (TTM) : 72.27M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 8.398B |
| Revolution Medicines, Inc. | 195.04M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| Structure Therapeutics, Inc. | 61.72M |